Entera Bio Ltd.
ENTX · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $181 | $0 | $134 | $571 |
| % Growth | – | -100% | -76.5% | – |
| Cost of Goods Sold | $172 | $56 | $165 | $373 |
| Gross Profit | $9 | -$56 | -$31 | $198 |
| % Margin | 5% | – | -23.1% | 34.7% |
| R&D Expenses | $4,499 | $4,454 | $5,784 | $6,771 |
| G&A Expenses | $5,095 | $0 | $0 | $5,690 |
| SG&A Expenses | $5,095 | $4,430 | $7,253 | $5,690 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$46 |
| Operating Expenses | $9,594 | $8,884 | $13,037 | $12,415 |
| Operating Income | -$9,585 | -$8,940 | -$13,068 | -$12,217 |
| % Margin | -5,295.6% | – | -9,752.2% | -2,139.6% |
| Other Income/Exp. Net | $58 | $80 | $134 | -$29 |
| Pre-Tax Income | -$9,527 | -$8,860 | -$12,934 | -$12,246 |
| Tax Expense | $14 | $29 | $137 | -$59 |
| Net Income | -$9,541 | -$8,889 | -$13,071 | -$12,187 |
| % Margin | -5,271.3% | – | -9,754.5% | -2,134.3% |
| EPS | -0.25 | -0.31 | -0.45 | -0.47 |
| % Growth | 19.4% | 31.1% | 4.3% | – |
| EPS Diluted | -0.25 | -0.31 | -0.45 | -0.47 |
| Weighted Avg Shares Out | 37,650 | 29,008 | 28,808 | 26,134 |
| Weighted Avg Shares Out Dil | 37,650 | 29,008 | 28,808 | 26,134 |
| Supplemental Information | – | – | – | – |
| Interest Income | $58 | $31 | $83 | $0 |
| Interest Expense | $0 | $0 | $0 | $29 |
| Depreciation & Amortization | $46 | $56 | $64 | $53 |
| EBITDA | -$9,539 | -$8,804 | -$12,870 | -$12,164 |
| % Margin | -5,270.2% | – | -9,604.5% | -2,130.3% |